Jab1 is overexpressed in human breast cancer and is a downstream target for HER-2/neu
2000 ◽
2001 ◽
2002 ◽
2003 ◽
2004 ◽
Keyword(s):
Decreased Response to Paclitaxel Versus Docetaxel in HER-2/neu Transfected Human Breast Cancer Cells
2003 ◽
Vol 26
(1)
◽
pp. 50-54
◽
Keyword(s):